Navigating metabolic pathways to enhance antitumour immunity and immunotherapy

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Nature Reviews Clinical Oncology

• Publication date

  2019-03-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41571-019-0203-7PMID 30914826
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostaglandins in asthma and allergic diseases☆

  2019cited by this paper
• CANTATA: A randomized phase 2 study of CB-839 in combination with cabozantinib vs. placebo with cabozantinib in patients with advanced/metastatic renal cell carcinoma.

  2018cited by this paper
• Electrophilic properties of itaconate and derivatives regulate the IκBζ–ATF3 inflammatory axis

  2018cited by this paper
• 4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses

  2018cited by this paper
• PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cells

  2018cited by this paper
• Trained immunity as a novel therapeutic strategy

  2018cited by this paper
• IDO takes a blow

  2018cited by this paper
• Metabolic interactions in cancer: cellular metabolism at the interface between the microenvironment, the cancer cell phenotype and the epigenetic landscape

  2018cited by this paper
• Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism.

  2018cited by this paper
• Targeting cancer's metabolic co-dependencies: A landscape shaped by genotype and tissue context.

  2018cited by this paper
• Mutant IDH (mIDH) inhibitors, ivosidenib or enasidenib, with azacitidine (AZA) in patients with acute myeloid leukemia (AML).

  2018cited by this paper
• Metabolic Hallmarks of Metastasis Formation.

  2018cited by this paper
• A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small cell lung cancer treated with PD-1 blockade

  2018cited by this paper
• Mitochondria‐Endoplasmic Reticulum Contact Sites Function as Immunometabolic Hubs that Orchestrate the Rapid Recall Response of Memory CD8+ T Cells

  2018cited by this paper
• The impact of metabolic reprogramming on dendritic cell function

  2018cited by this paper
• Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors

  2018cited by this paper
• Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions

  2018cited by this paper
• Acetylation accumulates PFKFB3 in cytoplasm to promote glycolysis and protects cells from cisplatin-induced apoptosis

  2018cited by this paper
• Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate

  2018cited by this paper
• Microenvironmental regulation of cancer cell metabolism: implications for experimental design and translational studies

  2018cited by this paper
• The metabolite BH4 controls T cell proliferation in autoimmunity and cancer

  2018cited by this paper
• Macrophage de novo NAD+ synthesis specifies immune function in aging and inflammation

  2018cited by this paper
• Reinforce the antitumor activity of CD8+ T cells via glutamine restriction

  2018cited by this paper
• GITR Agonism Enhances Cellular Metabolism to Support CD8+ T-cell Proliferation and Effector Cytokine Production in a Mouse Tumor Model

  2018cited by this paper
• Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy.

  2018cited by this paper
• Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer.

  2018cited by this paper
• NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control

  2018cited by this paper
• CD4 T cell autophagy is integral to memory maintenance

  2018cited by this paper
• PPAR-Induced Fatty Acid Oxidation in T Cells Increases the Number of Tumor-Reactive CD8+ T Cells and Facilitates Anti–PD-1 Therapy

  2018cited by this paper
• Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1

  2018cited by this paper
• Krebs Cycle Reimagined: The Emerging Roles of Succinate and Itaconate as Signal Transducers.

  2018cited by this paper
• Metabolism in cancer metastasis: bioenergetics, biosynthesis, and beyond

  2018cited by this paper
• Metabolism – A cornerstone of cancer initiation, progression, immune evasion and treatment response

  2018cited by this paper
• Durable Remissions with Ivosidenib in IDH1‐Mutated Relapsed or Refractory AML

  2018cited by this paper
• Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers

  2018cited by this paper
• Targeting Metabolism as a Novel Therapeutic Approach to Autoimmunity, Inflammation, and Transplantation

  2017cited by this paper
• PEGylated arginine deiminase can modulate tumor immune microenvironment by affecting immune checkpoint expression, decreasing regulatory T cell accumulation and inducing tumor T cell infiltration

  2017cited by this paper
• Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor

  2017cited by this paper
• Caspase-1 cleaves PPARγ for potentiating the pro-tumor action of TAMs

  2017cited by this paper
• Targeting immunosuppressive adenosine in cancer

  2017cited by this paper
• Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy.

  2017cited by this paper
• Understanding the Intersections between Metabolism and Cancer Biology.

  2017cited by this paper
• Mutant IDH1 regulates the tumor-associated immune system in gliomas

  2017cited by this paper
• Mitochondrial Priming by CD 28 Graphical Abstract Highlights

  2017cited by this paper
• A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients

  2017cited by this paper
• Lactate Metabolism in Human Lung Tumors.

  2017cited by this paper
• Prostaglandin E2 as a Regulator of Immunity to Pathogens

  2017cited by this paper
• Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas

  2017cited by this paper
• Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma.

  2017cited by this paper
• Structural features of subtype-selective EP receptor modulators.

  2017cited by this paper
• Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer

  2017cited by this paper
• Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy.

  2017cited by this paper
• Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression

  2017cited by this paper
• INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology

  2017cited by this paper
• Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma

  2017cited by this paper
• Combination therapy with L-arginine and α-PD-L1 antibody boosts immune response against osteosarcoma in immunocompetent mice

  2017cited by this paper
• Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells

  2017cited by this paper
• Amino-acid sensing and degrading pathways in immune regulation.

  2017cited by this paper
• Macrophage Metabolism As Therapeutic Target for Cancer, Atherosclerosis, and Obesity

  2017cited by this paper
• Mitochondrial activity in T cells.

  2017cited by this paper
• Glucose feeds the TCA cycle via circulating lactate

  2017cited by this paper
• α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming

  2017cited by this paper
• Elucidating immunometabolic targets in glioblastoma.

  2017cited by this paper
• Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment

  2017cited by this paper
• Pyruvate Kinase M2 Is Required for the Expression of the Immune Checkpoint PD-L1 in Immune Cells and Tumors

  2017cited by this paper
• Isocitrate dehydrogenase mutations in myeloid malignancies

  2016cited by this paper
• Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming.

  2016cited by this paper
• COX‐2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis

  2016cited by this paper
• Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α.

  2016cited by this paper
• Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

  2016cited by this paper
• The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction.

  2016cited by this paper
• Organ-Specific Cancer Metabolism and Its Potential for Therapy.

  2016cited by this paper
• High expression of CD39 in gastric cancer reduces patient outcome following radical resection.

  2016cited by this paper
• Trained immunity: A program of innate immune memory in health and disease

  2016cited by this paper
• Costimulation Endows Immunotherapeutic CD8 T Cells with IL-36 Responsiveness during Aerobic Glycolysis

  2016cited by this paper
• Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy.

  2016cited by this paper
• Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L

  2016cited by this paper
• Lactate promotes glutamine uptake and metabolism in oxidative cancer cells

  2016cited by this paper
• Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells.

  2016cited by this paper
• Targeting 6-phosphofructo-2-kinase (PFKFB3) as an immunotherapeutic strategy.

  2016cited by this paper
• 4-1BB signaling activates glucose and fatty acid metabolism to enhance CD8+ T cell proliferation

  2016cited by this paper
• Intermediates of Metabolism: From Bystanders to Signalling Molecules.

  2016cited by this paper
• Regulatory circuits of T cell function in cancer

  2016cited by this paper
• L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity

  2016cited by this paper
• LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells.

  2016cited by this paper
• In vivo cancer metabolism is defined by the nutrient microenvironment

  2016cited by this paper
• Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells.

  2016cited by this paper
• Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels*

  2016cited by this paper
• Ionic immune suppression within the tumour microenvironment limits T cell effector function

  2016cited by this paper
• Aspirin and colorectal cancer: the promise of precision chemoprevention

  2016cited by this paper
• mTORC1 and mTORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper T Cell Differentiation.

  2016cited by this paper
• From Krebs to clinic: glutamine metabolism to cancer therapy

  2016cited by this paper
• Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism

  2016cited by this paper
• TPL-2 Regulates Macrophage Lipid Metabolism and M2 Differentiation to Control TH2-Mediated Immunopathology

  2016cited by this paper
• Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity

  2016cited by this paper
• Altered metabolite levels in cancer: implications for tumour biology and cancer therapy

  2016cited by this paper
• The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway

  2016cited by this paper
• Increased expression of IDO associates with poor postoperative clinical outcome of patients with gastric adenocarcinoma

  2016cited by this paper
• Oncometabolites: Unconventional triggers of oncogenic signalling cascades

  2016cited by this paper
• Mammalian Target of Rapamycin Complex 2 Controls CD8 T Cell Memory Differentiation in a Foxo1-Dependent Manner.

  2016cited by this paper

• Engineering an immuno-nanoprodrug: Photo-controlled pyroptosis synergizing with acid-activatable immunometabolic blockade for potent cancer immunotherapy

  2026cites this paper
• Exploring the relationship between metabolism and immune microenvironment in breast cancer bone metastasis based on metabolic pathways

  2026cites this paper
• ERRα-ETV5 axis drives PD-L1 upregulation and immune escape in gallbladder cancer.

  2026cites this paper
• Adenosine receptors on the immuno-oncology expressway: TIME, perspectives, and translation

  2026cites this paper
• Immunometabolic heterogeneity in hepatocellular carcinoma: transforming cold tumors into hot tumors.

  2026cites this paper
• A serum metabolite-based machine learning model predicts response to neoadjuvant immunotherapy in mismatch repair-deficient colorectal cancer.

  2026cites this paper
• Defining the cellular and molecular identities of histologic subtypes in lung adenocarcinoma

  2026cites this paper
• Identification of glycolysis -correlative features for predicting prognosis and investigating immune landscape in prostate cancer.

  2026cites this paper
• Tumoral ALOX5 mediated arachidonic acid metabolism regulates immune response in non-small cell lung cancer

  2025cites this paper
• Overcoming resistance to anti-PD-L1 immunotherapy: mechanisms, combination strategies, and future directions

  2025cites this paper
• Self-Sustained Nanozyme Triggers Dual-Pronged Ferroptosis via ROS Storm and Barrier Collapse in a Remodeled Tumor Microenvironment

  2025cites this paper
• PRMT3 Drives IDO1-Dependent Radioresistance and Immunosuppression by Promoting Kynurenine Metabolism in Non–Small Cell Lung Cancer

  2025cites this paper
• Osteosarcoma immunometabolism: emerging mechanisms and clinical implications

  2025cites this paper
• Emerging Advances in Nanomedicine for Targeted Cancer Photoimmunotherapy and Photo‐Immunometabolic Therapy

  2025cites this paper
• New Frontier in Cancer Immunotherapy: Sexual Dimorphism of Immune Response

  2025cites this paper
• Bimetallic nanoadjuvant-mediated glutamine metabolism intervention and STING activation for enhanced antitumor immunity

  2025cites this paper
• Decoding the Metabolic-Immune Axis: Neutrophil Glycolysis-Driven Tumor Niche Remodeling and Its Therapeutic Exploitation.

  2025cites this paper
• Caffeine enhances antitumor T-cell activity by suppressing kynurenine pathway in colorectal cancer

  2025cites this paper
• FGA modulates immune infiltration and tumor progression via SLC7A11/xCT-mediated disulfidptosis in the tumor microenvironment of lung adenocarcinoma

  2025cites this paper
• Urea cycle dysregulation: a new frontier in cancer metabolism and immune evasion

  2025cites this paper
• Metabolic adaptations in cancer progression.

  2025cites this paper
• Targeting MondoA–TXNIP restores antitumour immunity in lactic-acid-induced immunosuppressive microenvironment

  2025cites this paper
• Metabolism‐Regulating Nanomedicines for Cancer Therapy

  2025cites this paper
• The integration of single-cell and metabolomics reveals the increase of oxidative phosphorylation during the liver metastasis of colorectal cancer

  2025cites this paper
• Integrative multi-omics reveals energy metabolism–related prognostic signatures and immunogenetic landscapes in lung adenocarcinoma

  2025cites this paper
• Black phosphorus nanosheets boost mitochondrial oxidative phosphorylation improving immunotherapy outcomes

  2025cites this paper
• Deciphering the Prognostic Landscape of Esophageal Adenocarcinoma: A PANoptosis-Related Gene Signature

  2025cites this paper
• Cancer suppresses mitochondrial chaperone activity in macrophages to drive immune evasion

  2025cites this paper
• Targeting Metabolic Reprogramming in Tumor: From Mechanisms to Precision Immunotherapies

  2025cites this paper
• Overcoming tumour resistance in cancer immunotherapy through predictive and pharmacodynamic biomarkers.

  2025cites this paper
• Inhibiting glycolysis facilitated checkpoint blockade therapy for triple-negative breast cancer

  2025cites this paper
• iMetAct: An integrated systematic inference of metabolic activity for dissecting tumor metabolic preference and tumor-immune microenvironment.

  2025cites this paper
• IRF8 and CD2 are potential targets of immunotherapy in non-small cell lung cancer

  2025cites this paper
• Metabolic reprogramming by chemo-gene co-delivery nanoparticles for chemo-immunotherapy in head and neck squamous cell carcinoma.

  2025cites this paper
• A novel 5-differentially expressed gene (DEG) signature predicting the prognosis in patients with metastatic liver malignancies and the prognostic and therapeutic potential of SPP1

  2025cites this paper
• Lung Adenocarcinoma Association Studies Based on Tumor Microenvironment Genes

  2025cites this paper
• Single-cell and spatial transcriptomic insights into glioma cellular heterogeneity and metabolic adaptations

  2025cites this paper
• Metabolism-related ALDH1B1 acts as potential predictor and therapeutic target for primary gastrointestinal diffuse large B-cell lymphoma

  2025cites this paper
• Magnetic Persistent Luminescence Nanoparticles Repolarize Tumor-Associated Macrophages for Enhanced Cancer Immunotherapy

  2025cites this paper
• Tumor immune evasion and the Let-7 family: insights into mechanisms and therapies

  2025cites this paper
• Recent advances in nanotechnology for metabolic cancer therapy

  2025cites this paper
• Enhancing CAR-T Cell Metabolic Fitness and Memory Phenotype for Improved Efficacy against Hepatocellular Carcinoma

  2025cites this paper
• Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies

  2025cites this paper
• The pivotal role of SFRP2 in promoting glycolysis and progression in the high-risk group based on the glycometabolism prognostic model for colorectal cancer

  2025cites this paper
• The glucose sensor NSUN2-m5C modification regulates tumor-immune glucose metabolism reprogramming to drive hepatocellular carcinoma evolution

  2025cites this paper
• USP30 inhibition augments mitophagy to prevent T cell exhaustion

  2025cites this paper
• Fe/Mo‐Based Lipid Peroxidation Nanoamplifier Combined with Adenosine Immunometabolism Regulation to Augment Anti‐Breast Cancer Immunity

  2025cites this paper
• Engineering glutamine-regulating nanomedicines for efficient tumor therapy

  2025cites this paper
• Editorial: The role of cell metabolism in development, drug resistance, and survival assessment in cancer

  2025cites this paper
• Immunometabolism: crosstalk with tumor metabolism and implications for cancer immunotherapy

  2025cites this paper
• The IFNγ‐CIITA‐MHC II axis modulates melanoma cell susceptibility to NK‐cell‐mediated cytotoxicity

  2025cites this paper
• Development of an ADME gene signature for prognostic and therapeutic stratification in gastric cancer

  2025cites this paper
• Evidence of fructose metabolism in colorectal cancer

  2025cites this paper
• Von Hippel–Lindau/Hypoxia Inducible Factor Axis in Glioblastoma

  2025cites this paper
• Metabolomic insights into pathogenesis and therapeutic potential in adult acute lymphoblastic leukemia

  2025cites this paper
• Identification and Validation of Cuproptosis-Related Signature to Predict Prognosis and Characterize Tumor Immune Infiltration in Kidney Clear Cell Carcinoma

  2025cites this paper
• Immunomodulatory behavior of CircRNAs in tumor microenvironment

  2025cites this paper
• TRIM28 drives immune evasion via PARP1 SUMOylation and NAD+ depletion in clear cell renal cell carcinoma

  2025cites this paper
• Parkin modulates the hepatocellular carcinoma microenvironment by regulating PD-1/PD-L1 signalling

  2025cites this paper
• Single-cell deconstruction of medulloblastoma microenvironment elucidates subtype-specific immune architectures and prognostic molecular signatures.

  2025cites this paper
• Identification and Analysis of Amino Acid Metabolism-Related Subtypes in Lung Adenocarcinoma.

  2025cites this paper
• The Clinical Prediction Value of the Ubiquitination Model Reflecting the Microenvironment Infiltration and Drug Sensitivity in Breast Cancer

  2025cites this paper
• Interferon-driven Metabolic Reprogramming and Tumor Microenvironment Remodeling

  2025cites this paper
• Predicting Outcomes in Esophageal Squamous Cell Carcinoma Using scRNA‐Seq and Bulk RNA‐Seq: A Model Development and Validation Study

  2025cites this paper
• Biomimetic calcium-chelation nanoparticles reprogram tumor metabolism to enhance antitumor immunity.

  2025cites this paper
• Recent advances of anti-tumor nano-strategies via overturning pH gradient: alkalization and acidification

  2025cites this paper
• The key role of the NUDT3 gene in lung adenocarcinoma progression and its association with the manganese ion metabolism family

  2025cites this paper
• Leptin decreases Th17/Treg ratio to facilitate neuroblastoma via inhibiting long-chain fatty acid catabolism in tumor cells

  2025cites this paper
• MnO2-Assisted Photosynthetic Bacteria Interfering with the Adenosine-A2AR Metabolic Pathway to Enhance Tumor Photothermal Immunotherapy.

  2025cites this paper
• Differences in immunogenicity of TP53-mutated cancers with low tumor mutational burden (TMB) A study on TP53mut endometrial-, ovarian- and triple-negative breast cancer.

  2025cites this paper
• Revolutionary Cancer Therapy for Personalization and Improved Efficacy: Strategies to Overcome Resistance to Immune Checkpoint Inhibitor Therapy

  2025cites this paper
• Asparagine deprivation enhances T cell antitumour response in patients via ROS-mediated metabolic and signal adaptations

  2025cites this paper
• Current advancement of immune function paradox of tumour-infiltrating cells and their immunotherapeutic targets: a mini-review

  2025cites this paper
• A Review of Metabolic Reprogramming in Cancer

  2025cites this paper
• Metabolic Reprogramming of Tumor Microenviroment by Engineered Bacteria.

  2025cites this paper
• Systematic exploration of prognostic alternative splicing events related to tumor immune microenvironment of Clear Cell Renal Cell Carcinoma

  2025cites this paper
• Carnitine palmitoyltransferase 2 as a novel prognostic biomarker and immunoregulator in colorectal cancer.

  2025cites this paper
• Age- and diet-instructed metabolic rewiring of the tumor-immune microenvironment.

  2025cites this paper
• Unmasking a Paradox: Roles of the PD-1/PD-L1 Axis in Alzheimer's Disease-Associated Neuroinflammation

  2025cites this paper
• PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis.

  2025cites this paper
• PLEKHA4 is transcriptionally regulated by HOXD9 and regulates glycolytic reprogramming and progression in glioblastoma via activation of the STAT3/SOCS-1 pathway

  2025cites this paper
• Clear cell renal cell carcinoma and metabolic reprogramming: New therapeutic targets for kidney cancer treatment

  2025cites this paper
• Using Multiomics and Machine Learning: Insights into Improving the Outcomes of Clear Cell Renal Cell Carcinoma via the SRD5A3-AS1/hsa-let-7e-5p/RRM2 Axis

  2025cites this paper
• Upregulation of PD-1 on Peripheral T cells Subsets is Associated with Parkinson's Disease

  2025cites this paper
• Impact of seasons on elderly patients with esophageal squamous cell carcinoma following esophagectomy: a propensity score matching analysis

  2025cites this paper
• UBE3C promotes pancreatic ductal adenocarcinoma progression by catalysing p53 ubiquitination

  2025cites this paper
• Biomineralized Engineered Bacterial Outer Membrane Vesicles as cGAS-STING Nanoagonists Synergize with Lactate Metabolism Modulation to Potentiate Immunotherapy.

  2025cites this paper
• Identification of prognostic-related tumor microenvironment genes in lung adenocarcinoma and establishment of a prognostic prediction model

  2025cites this paper
• Tumor-instructed glutamine synthesis in cancer-associated fibroblasts promotes pro-tumor macrophages.

  2025cites this paper
• Activating Mitochondrial Complex I by Polyphenol Nanoparticle to Inhibit Hypoxia-Inducible Factor-1 Subunit α for Immunotherapy.

  2025cites this paper
• Metabolic Reprogramming of Tumors: Induced Immunosuppression and Therapeutic Prospects of Nanoscale Drug Delivery Systems.

  2025cites this paper
• Mitophagy’s impacts on cancer and neurodegenerative diseases: implications for future therapies

  2025cites this paper
• Metabolic insights into TAMs and the tumor immune microenvironment: Regulatory mechanisms and therapeutic interventions.

  2025cites this paper
• Disulfidptosis Nanoinducer Interrupts Tumor Metabolic Privilege to Boost Sustained Immunotherapy.

  2025cites this paper
• The immune-related gene CD5 is a prognostic biomarker associated with the tumor microenvironment of breast cancer

  2025cites this paper
• Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy Breakout

  2025cites this paper
• Development and validation of an immune-related gene set (IRGS) model for prognostic and immunotherapeutic assessment in lung adenocarcinoma (LUAD)

  2025cites this paper
• Role of immune checkpoint inhibitors in breast cancer and hematological malignancies

  2025cites this paper
• Mito-Specific "Trojan Horse" Nanotherapy: Synergistic Antitumor Immunotherapy via Dual Modulation Mitochondrial Metabolism and Glycolysis.

  2025cites this paper
• Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy

  2025cites this paper